QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review (Q38244346)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

author name string

Mehrul Hasnain

1

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

W Victor R Vieweg

2

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

887-920

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

New Generation Antipsychotic Drugs and QTc Interval Prolongation

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Methadone and torsade de pointes: how can we better understand the association?

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Quetiapine and the need for a thorough QT/QTc study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Prediction of torsade de pointes from the QT interval: analysis of a case series of amisulpride overdoses

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Safety of amisulpride (Solian): a review of 11 clinical studies

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Amisulpride overdose: suggested management of prolonged QTc.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Torsade de pointes associated with low-dose amisulpride: a case report

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Two cases of amisulpride overdose: a cause for prolonged QT syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Ventricular ectopics during crossover of atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Asymptomatic bradycardia associated with amisulpride

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Minimal dose for severe poisoning and influencing factors in acute human clozapine intoxication: a 13-year retrospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Augmentation of clozapine with ziprasidone in refractory schizophrenia: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Dose dependent, new onset QTc prolongation in a patient with paranoid schizophrenia receiving Clozapine

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Clozapine associated dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Reversal of pathologic cardiac parameters after transition from clozapine to olanzapine treatment: a case report

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Sex differences in the effect of four second-generation antipsychotics on QTc interval in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

QTc changes after 6 months of second-generation antipsychotic treatment in children and adolescents

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Comparison of the metabolic effects observed in patients treated with ziprasidone versus olanzapine

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Cardiotoxicity in a citalopram and olanzapine overdose

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Temperament and character among Korean children and adolescents with anxiety disorders

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Antipsychotic Induced Prolongation of QTc Interval Treated with Magnesium

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

QTc prolongation and high-dose olanzapine.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Risk of cardiovascular morbidity with risperidone or paliperidone treatment: analysis of 64 randomized, double-blind trials

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Quetiapine poisoning: a case series

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Clinical and analytical features of severe suicidal quetiapine overdoses--a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Quetiapine overdose: predicting intubation, duration of ventilation, cardiac monitoring and the effect of activated charcoal.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Probable quetiapine-mediated prolongation of the QT interval

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Asymptomatic QTc prolongation associated with quetiapine fumarate overdose in a patient being treated with risperidone

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Pharmacokinetics of midazolam and metabolites in a patient with refractory status epilepticus treated with extraordinary doses of midazolam

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Acquired long QT interval: a case series of multifactorial QT prolongation

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Possible association of QTc interval prolongation with co-administration of quetiapine and lovastatin

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Pediatric case report of quetiapine overdose and QTc prolongation

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Torsades de pointes after administration of low-dose aripiprazole.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Multiple complications and withdrawal syndrome associated with quetiapine/venlafaxine intoxication

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Mental status change, myoclonus, electrocardiographic changes, and acute respiratory distress syndrome induced by quetiapine overdose.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Risperidone and corrected QT-interval prolongation in surface electrocardiogram

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Regular-dose risperidone on QTc intervals

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

QTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrations.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

ECG parameters in children and adolescents treated with aripiprazole and risperidone.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

QT interval and dispersion in very young children treated with antipsychotic drugs: a retrospective chart review

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Risperidone overdose causes extrapyramidal effects but not cardiac toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

A Randomized, Double-Blind Comparison of Risperidone Versus Low-Dose Risperidone Plus Low-Dose Haloperidol in Treating Schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Selective acquired long QT syndrome (saLQTS) upon risperidone treatment

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Torsade de pointes during combined treatment with risperidone and citalopram

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Acquired long QT syndrome: risperidone-facilitated triggered activity and Torsades de Pointes during complete AV block. I.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Torsades de pointes caused by a small dose of risperidone in a terminally ill cancer patient

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

QTc prolongation: possible association with risperidone and/or haloperidol

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Risperidone in the treatment of two very young children with autism

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Effect of sertindole on QTc interval in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

The effect of sertindole on QTD and TPTE.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

P wave and QT changes among inpatients with schizophrenia after parenteral ziprasidone administration.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

No significant QTc interval changes with high-dose ziprasidone: a case series.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Prospective observational multi-poison center study of ziprasidone exposures

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

QT interval duration and dispersion in children and adolescents treated with ziprasidone

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Ziprasidone in adolescents with schizophrenia: results from a placebo-controlled efficacy and long-term open-extension study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Ziprasidone in adolescents with autism: an open-label pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Single-dose pharmacokinetics and safety of ziprasidone in children and adolescents

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Ziprasidone: first year experience in a hospital setting

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS study.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Effectiveness, tolerability, and safety of ziprasidone in patients with schizophrenia or schizoaffective disorder: results of a multi-centre observational trial

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Efficacy and tolerability of switching to ziprasidone in italian patients with acute exacerbation of schizophrenia: an open-label trial

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Efficacy and tolerability of ziprasidone in patients with treatment-resistant schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Digital Holter measurement of QT prolongation in ziprasidone overdose

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Torsade de pointes after ziprasidone overdose with coingestants

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

The potential relationship between QTc interval prolongation and ziprasidone treatment: three cases

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Ziprasidone and hypokalemia: a case of 2 predisposing factors for QTc prolongation without development of torsades de pointes

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

QTc prolongation in multiple drug overdose

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Cardiotoxicity Associated with Intentional Ziprasidone and Bupropion Overdose#

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

QT interval and antidepressant use: a cross sectional study of electronic health records

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Antenatal use of selective serotonin-reuptake inhibitors and QT interval prolongation in newborns

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Clinical toxicology of citalopram after acute intoxication with the sole drug or in combination with other drugs: overview of 26 cases

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Comparison of toxicity of acute overdoses with citalopram and escitalopram

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Escitalopram causes fewer seizures in human overdose than citalopram.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Comparative toxicity of citalopram and the newer antidepressants after overdose.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Evaluation of a QT nomogram for risk assessment after antidepressant overdose.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Citalopram and levosulpiride: a dangerous drug combination for QT prolongation

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

The effect of age, sex, smoking and co-medication on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditions

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Torsade de pointes induced by citalopram and amiodarone.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Citalopram overdose: late presentation of torsades de pointes (TdP) with cardiac arrest

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Citalopram induced torsade de pointes, a rare life threatening side effect

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Cardiotoxicity and late onset seizures with citalopram overdose

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

QTc interval prolongation associated with citalopram overdose: a case report and literature review

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Prolonged lipemia and pancreatitis due to extended infusion of lipid emulsion in bupropion overdose.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Torsade de pointes associated with moxifloxacin: a rare but potentially fatal adverse event

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Cardiovascular safety of one-year escitalopram therapy in clinically nondepressed patients with acute coronary syndrome: results from the DEpression in patients with Coronary ARtery Disease (DECARD) trial

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

The cardiovascular safety profile of escitalopram.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Corrected QT interval prolongation after an overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepines

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Prolonged QTc interval in a 14-year-old girl with escitalopram overdose

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Low-dose escitalopram for 2 days associated with corrected QT interval prolongation in a middle-aged woman: a case report and literature review

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Sodium channel blockade with QRS widening after an escitalopram overdose

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Influence of coadministration of fluoxetine on cisapride pharmacokinetics and QTc intervals in healthy volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

QTc prolongation and torsades de pointes in an elderly woman taking fluoxetine.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Prolonged QT interval in an infant of a fluoxetine treated mother

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Fluoxetine (Prozac) as a cause of QT prolongation

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Fluoxetine and ventricular torsade — is there a link?

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Fluoxetine-induced cardiotoxicity with response to bicarbonate therapy

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Analysis of electrocardiographic data following use of paroxetine in pediatric depression and obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Coadministration of sertraline with cisapride or pimozide: an open-label, nonrandomized examination of pharmacokinetics and corrected QT intervals in healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Sertraline treatment of major depression in patients with acute MI or unstable angina

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

QT interval prolongation after sertraline overdose: a case report

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Cardiovascular effects of high dose venlafaxine XL in patients with major depressive disorder.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Electrocardiogram changes and arrhythmias in venlafaxine overdose

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

A comparison of venlafaxine and SSRIs in deliberate self-poisoning

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

The spectrum of acute heart failure after venlafaxine overdose

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

A fatal case of venlafaxine overdose

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Bias and variance evaluation of QT interval correction methods.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Problems of heart rate correction in assessment of drug-induced QT interval prolongation.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Searching for unpublished trials in Cochrane reviews may not be worth the effort

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Prolonged Tpeak-to-tend interval on the resting ECG is associated with increased risk of sudden cardiac death

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

How to correct the QT interval for the effects of heart rate in clinical studies

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Assessing QT interval prolongation and its associated risks with antipsychotics.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Prolonged QTc interval and risk of sudden cardiac death in a population of older adults

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Frequency of high-risk use of QT-prolonging medications

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Electrocardiographic reference ranges derived from 79,743 ambulatory subjects

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Metoprolol and diltiazem ameliorate ziprasidone-induced prolonged corrected QT interval in rats

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Drug-induced QTc-interval prolongation in the intensive care unit: incidence and predictors

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Genetics of congenital and drug-induced long QT syndromes: current evidence and future research perspectives

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Electrocardiogram-based predictors of clinical outcomes: a meta-analysis of the prognostic value of ventricular repolarization.

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Sertindole causes distinct electrocardiographic T-wave morphology changes

1 reference

https://api.crossref.org/works/10.1007%2FS40263-014-0196-9

21 January 2018

Evaluation of the effect of paliperidone extended release and quetiapine on corrected QT intervals: a randomized, double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular effects of paroxetine

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoxetine overdose-induced seizure

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine and associated QTc prolongation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

QTc prolongation associated with atypical antipsychotic use in the treatment of adolescent-onset anorexia nervosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

QT interval prolongation and torsade de pointes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of QTc interval prolongation and serum level of citalopram after intoxication--a case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

QT interval prolongation associated with quetiapine (Seroquel) overdose

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute oxcarbazepine and atomoxetine overdose with quetiapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of smoking on Tp-e interval, Tp-e/QT and Tp-e/QTc ratios as indices of ventricular arrhythmogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overdose of risperidone

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in the metabolic parameters and QTc interval after switching from olanzapine to aripiprazole in Japanese patients with stable schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-dependent effects of olanzapine on QT intervals and plasma prolactin levels in Japanese patients with stable schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrocardiographic changes and serum concentrations in thioridazine-treated patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

QTc prolongation: is clozapine safe? Study of 82 cases before and after clozapine treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged QTc interval and torsades de pointes induced by citalopram

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged QTc interval due to escitalopram overdose.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of risperidone on QT interval and QT dispersion in the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Life-threatening overdose with lamotrigine, citalopram, and chlorpheniramine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of paroxetine on the electrocardiogram

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

QTc Prolongation Associated with Ziprasidone Overdose.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multifactorial QT interval prolongation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Torsades de pointes associated with ziprasidone

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accurate electrocardiographic assessment of the QT interval: teach the tangent

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in QT interval after switching to quetiapine in Japanese patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

QT prolongation is an unreliable predictor of ventricular arrhythmia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-dose ziprasidone associated with QT interval prolongation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long QT syndrome caused by noncardiac drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

QTc interval and its variability in patients with schizophrenia and healthy subjects: implications for a thorough QT study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrocardiographic abnormalities in patients treated with clozapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug monitoring of a case of citalopram overdosage

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine rechallenge following QTc prolongation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 6-week, placebo-controlled studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone‐Induced QT Prolongation Following Overdose Correlates With Serum Drug Concentration and Resolves Rapidly With No Evidence of Altered Pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Symptoms and signs of severe citalopram overdose

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects on prolongation of Bazett's corrected QT interval of seven second-generation antipsychotics in the treatment of schizophrenia: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quetiapine and QTc issues: a case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Should the Physician's Desk Reference contraindicate the use of chlorpromazine-fluoxetine combination? A case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac safety of citalopram: prospective trials and retrospective analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

QT interval prolongation associated with venlafaxine administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The electrocardiogram as a tool for therapeutic monitoring: a critical analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of intramuscular ziprasidone for the control of acute psychosis or agitation in an inpatient geriatric population: an open-label study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe bradycardia in a stroke patient caused by a single low dose of escitalopram

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

QTc prolongation and clozapine: fact or artefact?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amisulpride deliberate self-poisoning causing severe cardiac toxicity including QT prolongation and torsades de pointes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fatal Cardiac Event following Initiation of Risperidone Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The QT interval

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uncomplicated metabolic syndrome is associated with prolonged electrocardiographic QTc interval and QTc dispersion

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic-induced QTc interval prolongation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine does not affect the cardiac safety and pharmacokinetics of terfenadine in healthy adult men

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Obesity, adiposity, and lengthening of the QT interval: improvement after weight loss

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in Chinese patients with risperidone as an active control: a randomized trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy and safety of 12 weeks of treatment with sertindole or olanzapine in patients with chronic schizophrenia who did not respond successfully to their previous treatments: a randomized, double-blind, parallel-group, flexible-dose study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Citalopram-induced long QT syndrome and torsade de pointes: role for concomitant therapy and disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot observational crossover study of QTc interval changes associated with switching between olanzapine and risperidone

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absence of cardiovascular adverse effects of sertraline in children and adolescents

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolerability and safety profile of risperidone in a sample of children and adolescents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of quetiapine in a patient with a massive overdose.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sudden cardiac death after treatment with low dose risperidone in combination with cotrimoxazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/25168784

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40263-014-0196-9

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38244346&oldid=2201461212"